UTHR
United Therapeutics Corporation
NASDAQ
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | ||||||||||||||||
| Operating Cash Flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net Income | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Depreciation & Amort. | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-Based Comp. | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Changes in WC | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Investing | ||||||||||||||||
| Capital Expenditures | 520.5M | 246.5M | 230.4M | 138.8M | 120.8M | 59.3M | 83.7M | 184.4M | 86.3M | 38.0M | 49.8M | 111.9M | 36.0M | 18.6M | 95.4M | 124.4M |
| Acquisitions | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Investing Cash Flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing | ||||||||||||||||
| Debt Repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Common Stock Issued | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Buybacks | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing Cash Flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Summary | ||||||||||||||||
| Free Cash Flow | 1.04B | 1.08B | 747.6M | 663.7M | 477.4M | 696.4M | -290.3M | 594.0M | 387.9M | 605.6M | 333.0M | 211.7M | 214.2M | 192.9M | 4.3M | -164.8M |
| Net Change in Cash | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |